• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[异基因骨髓移植后聚合酶链反应及抗原血症检测巨细胞病毒感染]

[Detection of cytomegalovirus infection with the polymerase chain reaction and antigenemia after allogenic bone marrow transplantation].

作者信息

Simková P, Jindra P, Koza V, Cerná K

机构信息

Hematologicko-onkologické oddĕlení FN, Plzen.

出版信息

Vnitr Lek. 2002 Feb;48(2):120-4.

PMID:11949219
Abstract

UNLABELLED

The objective of the work was to evaluate the frequency and time of incidence of cytomegaloviral (CMV) infection and disease in patients after allogeneic bone marrow transplantation (BMT). One hundred patients were followed up (70 with a related and 30 with an unrelated donor), who had transplantations during the period between XI/1996-XI/2000.

METHODS USED

nested-PCR (MIE-gene) and antigenaemia (antigen pp65). Active CMV infection was proved in antigenaemia > or = 5 positive cells or in two consecutive positive PCR. The CMV syndrome was assessed in confirmed CMV infection and otherwise inexplicable febrile conditions and/or a drop of haemogram values. For the diagnosis of CMV pneumonia the clinical picture was needed, evidence of active CMV infection and on the X-ray of the lungs interstitial pneumonia. In 33 patients both methods were used, in 67 only PCR. The first positive test appeared 6-321 days after BMT (median +/- 49 days). CMV infection was proved in 44% cases, CMV syndrome in 30% and CMV pneumonia in 4%. In patients with a related donor CMV infection was found in 34.3%, CMV syndrome in 22.9%, CMV pneumonia in 1.4%. After unrelated donor BMT CMV infection was recorded in 66.7%, CMV syndrome in 46.7% and CMV pneumonia in 10% patients. Two patients died from CMV pneumonia. CMV pneumonia was diagnosed 57-115 days after BMT (median +/- 68 days. The risk of CMV infection is high in both groups of patients, in particular in patients after unrelated donor BMT (66.7%). As far as the development of CMV pneumonia was concerned, the mortality in the authors' group was 50%.

摘要

未标注

本研究的目的是评估异基因骨髓移植(BMT)患者中巨细胞病毒(CMV)感染及疾病的发生频率和时间。对1996年11月至2000年11月期间接受移植的100例患者进行了随访(70例有血缘关系供者,30例有无血缘关系供者)。

使用的方法

巢式PCR(MIE基因)和抗原血症(抗原pp65)。当抗原血症中≥5个阳性细胞或连续两次PCR阳性时,证明存在活动性CMV感染。在确诊CMV感染且伴有无法解释的发热状况和/或血细胞计数下降时评估CMV综合征。诊断CMV肺炎需要临床表现、活动性CMV感染的证据以及肺部X线显示间质性肺炎。33例患者同时使用了两种方法,67例仅使用了PCR。首次阳性检测出现在BMT后6至321天(中位数±49天)。44%的病例证实有CMV感染,30%有CMV综合征,4%有CMV肺炎。有血缘关系供者的患者中,34.3%发现有CMV感染,22.9%有CMV综合征,1.4%有CMV肺炎。无血缘关系供者BMT后,66.7%的患者记录有CMV感染,46.7%有CMV综合征,10%有CMV肺炎。两名患者死于CMV肺炎。CMV肺炎在BMT后57至115天被诊断(中位数±68天)。两组患者中CMV感染风险都很高,尤其是无血缘关系供者BMT后的患者(66.7%)。就CMV肺炎的发生而言,作者组的死亡率为50%。

相似文献

1
[Detection of cytomegalovirus infection with the polymerase chain reaction and antigenemia after allogenic bone marrow transplantation].[异基因骨髓移植后聚合酶链反应及抗原血症检测巨细胞病毒感染]
Vnitr Lek. 2002 Feb;48(2):120-4.
2
Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.异基因外周血干细胞移植后持续巨细胞病毒pp65抗原血症和巨细胞病毒间质性肺炎的风险降低。
Bone Marrow Transplant. 2000 Mar;25(6):665-72. doi: 10.1038/sj.bmt.1702216.
3
Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.在异基因骨髓移植后,使用pp65抗原血症检测法、CMV核酸扩增检测法以及半定量聚合酶链反应检测法分析巨细胞病毒(CMV)病毒血症。
Transpl Infect Dis. 2007 Mar;9(1):16-21. doi: 10.1111/j.1399-3062.2006.00171.x.
4
Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.巨细胞病毒感染的监测:骨髓移植患者全血PCR、血浆PCR、pp65抗原血症检测及病毒培养的比较
Bone Marrow Transplant. 1996 May;17(5):861-8.
5
[Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].[通过空斑小室细胞培养、抗原血症检测及实时聚合酶链反应对高危患者外周血样本中巨细胞病毒阳性情况的调查]
Mikrobiyol Bul. 2011 Apr;45(2):288-95.
6
Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group.来自无关供者的异基因骨髓移植后巨细胞病毒(CMV)感染及CMV相关疾病的发生率增加。福冈骨髓移植研究组。
Bone Marrow Transplant. 1997 Feb;19(3):241-8. doi: 10.1038/sj.bmt.1700637.
7
Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.异基因造血干细胞移植后巨细胞病毒再激活的监测:抗原血症检测与定量实时聚合酶链反应的比较
Bone Marrow Transplant. 2002 Apr;29(7):599-606. doi: 10.1038/sj.bmt.1703513.
8
Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.巨细胞病毒抗原血症检测或聚合酶链反应可用于监测骨髓移植受者的更昔洛韦治疗。
Bone Marrow Transplant. 1992 Apr;9(4):247-53.
9
Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.PCR血清在诊断和监测骨髓移植受者巨细胞病毒再激活中的应用。
Int J Hematol. 1999 Feb;69(2):105-11.
10
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.一项前瞻性研究,比较血浆中巨细胞病毒(CMV)定量聚合酶链反应和pp65抗原血症检测在监测异基因干细胞移植患者中的作用。
BMC Infect Dis. 2006 Nov 21;6:167. doi: 10.1186/1471-2334-6-167.